SCHEMBL27019883

SCHEMBL27019883

CC(C)CCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT14 O95848 2/20 0.66
NUDT5 Q9UKK9 2/20 0.66
BTK Q06187 13/20 0.64
PIK3CD O00329 1/20 0.64
PIK3CA P42336 1/20 0.64
PIK3CB P42338 1/20 0.64
PIK3CG P48736 1/20 0.64
PRKDC P78527 1/20 0.64
LCK P06239 5/20 0.61
ITK Q08881 3/20 0.61
EGFR P00533 2/20 0.61
JAK3 P52333 2/20 0.61
FYN P06241 9/20 0.56
BMX P51813 3/20 0.56
SRC P12931 5/20 0.55
LYN P07948 5/20 0.55
FLT3 P36888 4/20 0.55
PTK6 Q13882 4/20 0.55
HCK P08631 3/20 0.55
FGR P09769 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27019885 0.94 PIK3CD (0.72) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL25479854 0.87 BTK (0.69) NUDT14NUDT5BTKLCKITK
SCHEMBL24458025 0.87 BTK (0.69) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL25068911 0.87 NUDT14 (0.62) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL15916593 0.86 BTK (0.67) NUDT14NUDT5BTKLCKITK
SCHEMBL23409030 0.86 NUDT14 (0.66) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL15576287 0.86 NUDT14 (0.66) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL13861437 0.85 BTK (0.72) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL29665672 0.85 BTK (0.72) NUDT14NUDT5BTKPIK3CDPIK3CA
SCHEMBL25069017 0.85 NUDT14 (0.68) NUDT14NUDT5BTKPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2024-01-18 US disclosed
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF ABCG2, ABCB1, ARSA NUDT14 1332/4885NUDT5 1313/4885BTK 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.